The Journal of Immunology, Vol 142, Issue 6 2024-2030, Copyright © 1989 by American Association of Immunologists

ARTICLES

Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma

RA Brooimans, PS Hiemstra, AA van der Ark, RB Sim, LA van Es and MR Daha
Department of Nephrology, University Hospital Leiden, The Netherlands.

The present studies were initiated to characterize a 150-kDa molecule with inhibitory activity for C3bBb formation, which is present in human umbilical vein endothelial cells (HUVEC). Therefore, human endothelial culture supernatants (HECS) were analyzed for the presence of human complement factor H by ELISA. It was found that H was present in HECS. An immunoblot analysis of affinity purified H from HECS showed that the size of HUVEC H was identical to that of plasma H. The mean production of H by HUVEC of first passage cultures was 40 ng/10(6) cells/day. The synthesis of HUVEC H was fully inhibitable by the addition of cycloheximide to the cultures, suggesting that H is de novo synthesized. Additional evidence for de novo synthesis was obtained by using biosynthetic labeling with [35S] methionine, immunoprecipitation, and SDS-PAGE. It was demonstrated that, indeed, HUVEC produce and secrete factor H. Two forms of the protein were identified, the 150-kDa form and also a 45-kDa form, both forms have been identified in plasma. The functional activity of HUVEC H is identical to that of plasma H. IFN-gamma induced enhanced synthesis of H by HUVEC, whereas it had no effect on C3 synthesis. Supernatant from stimulated PBMC, T cell growth factor, enhanced synthesis of both H and C3. The present studies indicate that H is produced by HU-VEC and that H may function as an inhibitor of complement activation at the endothelial cell level and, thereby, together with molecules like decay accelerating factor and membrane cofactor protein, may influence resistance of endothelial cells to complement mediated damage.

This article has been cited by other articles:

				L. Liang and B. Roizman Expression of Gamma Interferon-Dependent Genes Is Blocked Independently by Virion Host Shutoff RNase and by US3 Protein Kinase J. Virol., May 15, 2008; 82(10): 4688 - 4696. [Abstract] [Full Text] [PDF]

				T. MONSINJON, P. GASQUE, P. CHAN, A. ISCHENKO, J. J. BRADY, and M. FONTAINE Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells FASEB J, June 1, 2003; 17(9): 1003 - 1014. [Abstract] [Full Text] [PDF]

				E. A. Lidington, D. O. Haskard, and J. C. Mason Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury Blood, October 15, 2000; 96(8): 2784 - 2792. [Abstract] [Full Text] [PDF]

				A. Thomas, P. Gasque, D. Vaudry, B. Gonzalez, and M. Fontaine Expression of a complete and functional complement system by human neuronal cells in vitro Int. Immunol., July 1, 2000; 12(7): 1015 - 1023. [Abstract] [Full Text] [PDF]

				J. C. Mason, H. Yarwood, K. Sugars, B. P. Morgan, K. A. Davies, and D. O. Haskard Induction of Decay-Accelerating Factor by Cytokines or the Membrane-Attack Complex Protects Vascular Endothelial Cells Against Complement Deposition Blood, September 1, 1999; 94(5): 1673 - 1682. [Abstract] [Full Text] [PDF]

				R. H. van den Berg, M. C. Faber-Krol, R. B. Sim, and M. R. Daha The First Subcomponent of Complement, C1q, Triggers the Production of IL-8, IL-6, and Monocyte Chemoattractant Peptide-1 by Human Umbilical Vein Endothelial Cells J. Immunol., December 15, 1998; 161(12): 6924 - 6930. [Abstract] [Full Text] [PDF]

				B. H. Ault, B. Z. Schmidt, N. L. Fowler, C. E. Kashtan, A. E. Ahmed, B. A. Vogt, and H. R. Colten Human Factor H Deficiency. MUTATIONS IN FRAMEWORK CYSTEINE RESIDUES AND BLOCK IN H PROTEIN SECRETION AND INTRACELLULAR CATABOLISM J. Biol. Chem., October 3, 1997; 272(40): 25168 - 25175. [Abstract] [Full Text] [PDF]